CME Stock Analysis: CME | NASDAQ
Financial Data & Stock Exchanges | NASDAQ, USA | Market Cap: 110.024m USD | 12M Return: 18.1% | US12572Q1058 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 549M
EPS Trend: 99.4%
Qual. Beats: 2
Rev. Trend: 98.7%
Qual. Beats: 2
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
CME Group Inc. operates one of the worlds largest derivatives marketplaces, offering futures and options contracts across asset classes including interest rates, equity indexes, foreign exchange, and agricultural, energy, and metals commodities. Beyond trade execution, the company runs the central counterparty clearing function, guaranteeing and settling contracts and cleared swaps, which is a core revenue and risk-management pillar of the exchange business model. It also sells real-time and historical market data to a broad client base spanning professional traders, institutions, corporations, governments, and central banks. The company traces its origins to 1898 in Chicago and rebranded from Chicago Mercantile Exchange Holdings Inc. to CME Group Inc. in July 2007.
- Interest rate volatility drives Treasury futures trading volumes
- Geopolitical uncertainty boosts commodities and FX hedging demand
- Market data and analytics segment revenue expands steadily
| Net Income: 4.40b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.00 > 1.0 |
| NWC/Revenue: 43.39% < 20% (prev 50.23%; Δ -6.84% < -1%) |
| CFO/TA 0.02 > 3% & CFO 4.28b > Net Income 4.40b |
| Net Debt (1.10b) to EBITDA (6.63b): 0.17 < 3 |
| Current Ratio: 1.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (358.6m) vs 12m ago -0.47% < -2% |
| Gross Margin: 84.32% > 18% (prev 86.14%; Δ -1.82% > 0.5%) |
| Asset Turnover: 3.68% > 50% (prev 3.42%; Δ 0.26% > 0%) |
| Interest Coverage Ratio: 36.11 > 6 (EBIT TTM 6.30b / Interest Expense TTM 174.4m) |
| A: 0.02 (Total Current Assets 159b - Total Current Liabilities 156b) / Total Assets 192b |
| B: 0.03 (Retained Earnings 6.03b / Total Assets 192b) |
| C: 0.03 (EBIT TTM 6.30b / Avg Total Assets 190b) |
| D: 0.16 (Book Value of Equity 26.6b / Total Liabilities 166b) |
| Altman-Z'' = 0.60 = B |
| DSRI: 1.12 (Receivables 788.1m/642.9m, Revenue 6.97b/6.40b) |
| GMI: 1.02 (GM 86.14% / 84.32%) |
| AQI: 0.93 (AQ_t 0.17 / AQ_t-1 0.18) |
| SGI: 1.09 (Revenue 6.97b / 6.40b) |
| TATA: 0.00 (NI 4.40b - CFO 4.28b) / TA 192b) |
| Beneish M = -2.88 (Cap -4..+1) = A |
As of October 24, 2026, the stock is trading at USD 305.71 with a total of 2,180,226 shares traded. Over the past week, the price has changed by +4.03%, over one month by +12.89%, over three months by +20.77% and over the past year by +18.10%.
Current recommended Stop Loss: 296.20 (which is 3.1% or 1.5 ATR below the current price).
CME has received a consensus analysts rating of 3.47. Therefore, it is recommended to hold CME.
- StrongBuy: 4
- Buy: 4
- Hold: 6
- Sell: 2
- StrongSell: 1
| Analysts Target Price | 310.1 | 1.4% |
P/E Trailing = 24.2456
P/E Forward = 21.9298
P/S = 15.8115
P/B = 3.6717
P/EG = 4.7092
Revenue TTM = 6.97b USD
EBIT TTM = 6.30b USD
EBITDA TTM = 6.63b USD
Long Term Debt = 3.42b USD (from longTermDebt, last fiscal year)
Short Term Debt = 55.8m USD (from shortTermDebt, last fiscal year)
Debt = 3.43b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.10b USD (calculated: Debt 3.43b - CCE 2.33b)
Enterprise Value = 111b USD (110b + Debt 3.43b - CCE 2.33b)
Interest Coverage Ratio = 36.11 (Ebit TTM 6.30b / Interest Expense TTM 174.4m)
EV/FCF = 26.50x (Enterprise Value 111b / FCF TTM 4.19b)
FCF Yield = 3.77% (FCF TTM 4.19b / Enterprise Value 111b)
FCF Margin = 60.15% (FCF TTM 4.19b / Revenue TTM 6.97b)
Net Margin = 63.12% (Net Income TTM 4.40b / Revenue TTM 6.97b)
Gross Margin = 84.32% ((Revenue TTM 6.97b - Cost of Revenue TTM 1.09b) / Revenue TTM)
Gross Margin QoQ = 94.00% (prev 69.25%)
Tobins Q-Ratio = 0.58 (Enterprise Value 111b / Total Assets 192b)
Interest Expense / Debt = 5.09% (Interest Expense 174.4m / Debt 3.43b)
Taxrate = 23.75% (1.37b / 5.77b)
NOPAT = 4.80b (EBIT 6.30b * (1 - 23.75%))
Current Ratio = 1.02 (Total Current Assets 159b / Total Current Liabilities 156b)
Debt / Equity = 0.13 (Debt 3.43b / totalStockholderEquity, last quarter 26.6b)
Debt / EBITDA = 0.17 (Net Debt 1.10b / EBITDA 6.63b)
Debt / FCF = 0.26 (Net Debt 1.10b / FCF TTM 4.19b)
Total Stockholder Equity = 27.1b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.32% (Net Income 4.40b / Total Assets 192b)
RoE = 16.24% (Net Income TTM 4.40b / Total Stockholder Equity 27.1b)
RoCE = 20.63% (EBIT 6.30b / Capital Employed (Equity 27.1b + L.T.Debt 3.42b))
RoIC = 13.46% (NOPAT 4.80b / Invested Capital 35.7b)
WACC = 4.77% (E(110b)/V(113b) * Re(4.80%) + D(3.43b)/V(113b) * Rd(5.09%) * (1-Tc(0.24)))
Discount Rate = 4.80% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 29.26 | Cagr: -0.15%
[DCF] Terminal Value 75.79% ; FCFF base≈4.15b ; Y1≈4.26b ; Y5≈4.72b
[DCF] Fair Price = 200.0 (EV 73.0b - Net Debt 1.10b = Equity 71.9b / Shares 359.6m; r=8.35% [WACC [floored]]; 5y FCF grow 2.69% → 2.50% )
EPS Correlation: 99.39 | EPS CAGR: 10.33% | SUE: 1.19 | # QB: 2
Revenue Correlation: 98.68 | Revenue CAGR: 8.34% | SUE: 1.18 | # QB: 2
EPS current Quarter (2027-03-31): EPS=3.32 | Chg30d=+1.30% | Revisions=-10% | Analysts=12
EPS current Year (2026-12-31): EPS=12.43 | Chg30d=+1.47% | Revisions=+46% | GrowthEPS=+11.0% | GrowthRev=+8.9%
EPS next Year (2027-12-31): EPS=13.19 | Chg30d=+2.05% | Revisions=+46% | GrowthEPS=+6.1% | GrowthRev=+4.8%
[Analyst] Revisions Ratio: +37% (up=19, down=8)